China tightens grip on biotech platform ownership but foreign licensing deals still okay
China’s government has proposed a ban on the sale of certain biotechnology platforms, including cell and gene therapy tech—but the policy does not apply to the lucrative licensing deals that have been proliferating in the region. The new policy from China’ …